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import of PTS1 matrix proteins into peroxisomes is 
indeed a redox-regulated process, and that this 
redox-sensitivity is mediated by PEX5, the shuttling 
receptor for PTS1 proteins. In addition, it 
demonstrates that Cys11 of human PEX5 functions 
as a redox switch that modulates PEX5 activity in 
response to intracellular oxidative stress, most likely 
by modulating its monoubiquitination at the 
peroxisomal membrane. 
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Abstract 
Peroxisome maintenance depends on the import of 
nuclear-encoded proteins from the cytosol. The vast 
majority of these proteins is destined for the 
peroxisomal lumen and contains a C-terminal 
peroxisomal targeting signal, called PTS1. This 
targeting signal is recognized in the cytosol by the 
receptor PEX5. After docking at the peroxisomal 
membrane and release of the cargo into the 
organelle matrix, PEX5 is recycled to the cytosol 
through a process requiring monoubiquitination of 
an N-terminal, cytosolically-exposed cysteine 
residue (Cys11 in the human protein). At present, 
the reason why a cysteine, and not a lysine residue, 
is the target of ubiquitination remains unclear. Here, 
we provide evidence that PTS1 protein import into 
human fibroblasts is a redox-sensitive process. We 
also demonstrate that Cys11 in human PEX5 
functions as a redox switch that regulates PEX5 
activity in response to intracellular oxidative stress. 
Finally, we show that exposure of human PEX5 to 
oxidized glutathione results in a ubiquitination-
deficient PEX5 molecule, and that substitution of 
Cys11 by a lysine can counteract this effect. In 
summary, these findings reveal that the activity of 
PEX5, and hence PTS1 import, is controlled by the 
redox state of the cytosol. The potential 
physiological implications of these findings are 
discussed. 
 
Introduction 
Peroxisomes are multifunctional organelles that, 
among other functions, participate in cellular lipid 
and reactive oxygen species (ROS) metabolism 
(1,2). Defects in peroxisome function are at the core 
of several fatal genetic disorders (3). In addition, 
there is growing evidence that peroxisome biology 
and cellular aging are closely intertwined (4). For 
example, inhibition of the activity of catalase, the 
most abundant peroxisomal antioxidant enzyme, 
causes a cascade of accelerated aging reactions 
such as increased mitochondrial ROS production, 
oxidative damage to proteins and DNA, hyper-
secretion of matrix metalloproteinases, and impaired 
cell growth (5,6). On the other hand, increased 
cellular oxidative stress (e.g. during cellular aging) 
leads to a reduced import efficiency of peroxisomal 
matrix proteins containing a C-terminal peroxisomal 
targeting signal type 1 (PTS1), especially catalase 
(7). The molecular mechanisms underlying these 
phenomena are far from being understood. 
However, in this context, it should be mentioned that 
(i) under conditions of oxidative stress, PEX5, the 
shuttling import receptor for PTS1 proteins, 
accumulates at the peroxisome membrane, and (ii) 
the cellular senescence phenotypes in old cells can 
be reversed by overexpression of catalase-SKL, a 
catalase derivative with enhanced peroxisome 
targeting efficiency (8). 
The assembly of functional peroxisomes requires 
the import of both membrane and matrix proteins 
(9). The vast majority of matrix proteins contain a 
PTS1. This class of proteins is synthesized on free 
polyribosomes in the cytosol and posttranslationally 
recognized by the shuttling import receptor PEX5 
while still in the cytosol. The PEX5-cargo protein 
complex then interacts with the peroxisomal 
docking/translocation machinery (DTM). This 
interaction ultimately leads to the insertion of PEX5 
into the DTM with the concomitant translocation of 
the cargo protein across the peroxisomal 
membrane. Interestingly, a 2-kDa N-terminal region 
 2
of PEX5 containing a phylogenetically conserved 
cysteine residue remains exposed to the cytosol 
during this process. After cargo release, PEX5 is 
monoubiquitinated at this conserved cysteine 
residue (Cys11), and extracted from the DTM by the 
ATP-dependent receptor export module (REM) (10-
12). Once back in the cytosol, the ubiquitin moiety 
attached to PEX5 is removed, probably by a 
combination of enzymatic and non-enzymatic 
mechanisms (13,14). This resets PEX5 for the next 
round of import. 
Protein ubiquitination is a posttranslational 
modification that controls many intracellular 
processes (15,16). In general, this modification 
results in the attachment of a ubiquitin molecule to 
an ε-amino group of a substrate lysine residue (17). 
However, in a select set of proteins (e.g. PEX5), 
ubiquitin is transferred onto a cysteine residue 
yielding a thioester (18). The physiological 
relevance and role of this unconventional type of 
ubiquitination is puzzling. On one hand, it is well 
known that thioesters are easily disrupted by 
nucleophiles such as GSH (19). On the other hand, 
it has been reported that substitution of the cysteine 
at position 11 by lysine in human PEX5 results in a 
fully functional PTS1 import receptor, at least under 
standard laboratory conditions (13). Prompted by 
the combined observations that (i) PEX5 
accumulates at the peroxisomal membrane upon 
oxidative stress (8), (ii) this peroxin needs to be 
monoubiquitinated at a conserved cysteine residue 
in order to be exported back to the cytosol (20,21), 
and (iii) there is an ever increasing number of 
examples in which the activity of proteins (e.g. 
transcription factors, kinases, phosphatases, etc.) is 
controlled by the oxidation states of cysteines (22), 
we recently hypothesized that Cys11 in human 
PEX5 may serve as a functional redox switch 
regulating the peroxisomal/cytosolic localization of 
peroxisomal proteins such as catalase (2). In this 
report, we provide experimental evidence in favor of 
this hypothesis. 
 
Results 
 
Redox regulation of PTS1 protein import into 
peroxisomes 
Previously, we and others have shown that there is 
a strong correlation between cellular aging, 
oxidative stress, and PTS1 protein import into 
peroxisomes (7,8,23). To strengthen the concept 
that changes in the cellular redox state may have 
wide-ranging consequences for peroxisomal matrix 
protein import, we cultivated human fibroblasts 
(passage 35) under different redox conditions and 
studied the subcellular localization of roGFP2-PTS1, 
a peroxisome-targeted variant of roGFP2 (Fig. 1A). 
RoGFP2 is a redox-sensitive form of the enhanced 
green fluorescent protein (EGFP) that contains two 
engineered cysteine residues on adjacent surface-
exposed strands close to the chromophore (24). As 
(i) roGFP2 has two fluorescence excitation maxima 
at ∼400 and ∼490 nm, and (ii) disulfide bond 
formation between the engineered cysteine residues 
leads to an increase in the excitation peak at ∼400 
nm at the expense of the ∼490 nm peak, the ratio of 
roGFP2 emissions (at ∼510 nm) can provide a non-
destructive read-out of the redox environment of the 
chromophore (24). To determine the effects of 
different treatments on the redox state of the 
cytosol, we employed non-targeted, i.e. cytosolic, 
roGFP2 (23). We found that overexpression of 
catalase, a peroxisomal H2O2-decomposing enzyme 
whose activity drops during in vitro cellular aging 
(25), significantly lowers the redox state of the 
cytosol (Fig. 1B) and largely restores PTS1 protein 
import (Fig. 1C). A similar result was obtained when 
the cells were cultivated overnight in medium 
containing 0.5 mM dithiothreitol (DTT), a 
membrane-permeable reducing agent (Figs. 1B and 
1C). For comparison, we also included the values 
we obtained for these fibroblasts at passage 15 
(Figs. 1B and 1C). Taken together, these findings 
lend support to the idea that the import of PTS1 
proteins into peroxisomes is a redox-regulated 
process. 
 
The redox-dependent changes in PTS1 import 
efficiency involve the evolutionarily conserved 
cysteine residue in the N-terminal domain of 
PEX5 
As (i) PTS1 proteins are imported into peroxisomes 
by the shuttling receptor PEX5 (9), (ii) this receptor 
accumulates at the peroxisomal membrane in aging 
cells (7), and (iii) the export of PEX5 from the 
peroxisomal membrane to the cytosol depends on 
the evolutionarily conserved cysteine residue in the 
N-terminal region of the protein (20), we 
investigated whether or not this cysteine can act as 
a redox-sensitive regulatory switch for PEX5 
activity. Therefore, we complemented late-passage 
primary human fibroblasts (HuFs) lacking functional 
PEX5 (hereafter called PEX5 null; for more details, 
see “Materials and Methods”) with constructs 
encoding human PEX5WT or PEX5C11K and 
determined how efficiently the expression of both 
PEX5 variants restored PTS1 protein import. The 
reasoning behind this experiment was that – in case 
Cys11 does indeed function as a redox switch – 
PEX5C11K, a peroxisomal import/export-competent 
protein (13), should restore PTS1 import more 
efficiently than PEX5WT in cells with an increased 
cytosolic redox state. To exclude the possibility that 
any observed differences are the indirect result of 
non-redox regulated events, we also performed 
similar experiments in the corresponding 
transformed HuFs, which display a lower cytosolic 
redox state (see below). The results of these 
experiments are presented in Fig. 2A. From these 
data, it is clear that (i) the import of roGFP2-PTS1 
into peroxisomes is PEX5-dependent, (ii) PEX5WT is 
less functional in late-passage primary cells than in 
transformed cells, and (iii) the replacement of 
cysteine at position 11 by a lysine in PEX5 
dramatically increases its functionality in late-
passage primary cells. To provide unambiguous 
evidence that the differences observed in primary 
and transformed cells expressing PEX5WT and 
PEX5C11K are redox-related and not simply due to 
differences in expression or stability of these PEX5 
proteins, we confirmed that transformation of the 
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PEX5 null HuFs led to a more reduced redox state 
of the cytosol (Fig. 2B) and studied the effect of the 
thiol-reducing agent N-acetyl-cysteine (NAC) on the 
complementation activity of PEX5WT and PEX5C11K 
(Fig. 3). Importantly, treatment of the cells with 
NAC, a compound that shifts the redox state of the 
cytosol toward lower values (26) (Fig. 3A), resulted 
in an increased functionality of PEX5WT, but not of 
PEX5C11K (Figs 3B and 3C). Note that the results 
obtained for PEX5C11K also exclude the possibility 
that the differences in import kinetics observed for 
PEX5WT upon NAC treatment are the result of 
redox-related structural changes of the roGFP2-
PTS1 reporter protein. All together, these 
experiments suggest that Cys11 of human PEX5 
functions as a redox switch that modulates PEX5 
activity in response to intracellular oxidative stress. 
 
Exposure of human PEX5 to oxidized 
glutathione impairs its monoubiquitination in a 
Cys11-dependent manner 
To determine whether or not oxidation of human 
PEX5 affects its monoubiquitination at Cys11, we 
incubated 35S-labeled PEX5WT or PEX5C11K with a 
(peroxisome-containing) rat liver postnuclear 
supernatant supplemented with ATP and GST-
tagged ubiquitin (GST-Ub) in the absence or 
presence of increasing concentrations of oxidized 
glutathione (GSSG) (for detailed procedures, see 
“Materials and Methods”). Organelles were then 
processed for SDS-PAGE under non-reducing and 
reducing conditions, and the amounts of 35S-labeled 
GST-Ub-PEX5 species that were produced in these 
in vitro assays were assessed by autoradiography 
(Fig. 4). As shown in Fig. 4 (upper panel), 
monoubiquitination of PEX5WT is much more 
sensitive to GSSG than monoubiquitination of 
PEX5C11K. Note that PEX5 monoubiquitination 
detected in these assays occurs at its residue 11, 
because treatment of protein samples with DTT 
destroys the thioester bond between GST-Ub and 
PEX5WT but not the amide bond that links GST-Ub 
to PEX5C11K (Fig. 4, lower panel; see also (13)). The 
reduction in PEX5C11K monoubiquitination observed 
with the highest concentration of GSSG (Fig. 4, 
upper panel) is probably due to the fact that the 
ubiquitination cascade comprises cysteine-
containing enzymes (the ubiquitin-activating enzyme 
and ubiquitin-conjugating enzymes) that are also 
potential targets of GSSG (27). In summary, these 
data strongly indicate that Cys11 in human PEX5 is 
the most oxidative stress-sensitive cysteine of the 
complete PEX5 monoubiquitination process. 
Discussion 
In this study, we have provided experimental 
evidence that (i) PTS1 protein import is a redox-
sensitive process, (ii) this redox sensitivity is 
mediated by PEX5, the shuttling receptor for 
peroxisomal matrix proteins, and (iii) the cysteine at 
position 11 in human PEX5 functions as a redox 
switch that regulates PEX5 activity in response to 
oxidative stress, most likely by modulating its 
monoubiquitination at the DTM. In summary, these 
findings provide a molecular explanation for the 
long-standing observation that peroxisomal PTS1 
protein import is reduced in cells experiencing 
oxidative stress (7,28). In addition, as PEX5 
monoubiquitination at Cys11 is necessary for the 
export of the receptor back into the cytosol (20,21), 
these data also explain why PEX5 accumulates on 
peroxisomal membranes during cellular aging (7), a 
condition associated with a sharp increase in the 
cytosolic redox state (23,29). In the context of these 
results, it is important to recognize that also 
additional mechanisms may be at play in relation to 
the inhibitory effects of oxidative stress on 
peroxisomal protein import. For example, as 
oxidative stress can decrease both glycolytic and 
mitochondrial ATP production (30, 31), it is very 
likely that this type of stress can also impede the 
ATP-dependent export step of PEX5 from the 
peroxisomal membrane to the cytosol. In addition, 
one can easily envisage a scenario in which 
oxidative stress leads to the modification and partial 
inactivation of non-PEX5-related components of the 
peroxisomal protein import and protein quality 
control machineries (32,33). However, as (i) such 
alternative mechanisms can be expected to equally 
reduce the functionality of PEX5WT and PEX5C11K, 
and (ii) this is not the case in the experiments 
discussed here, they seem to be of no importance 
under the conditions studied. 
Over the years, accumulating evidence has 
strengthened the view that peroxisomal metabolism, 
cellular oxidative balance, and cellular aging are 
intimately interconnected (2,4,34). In the context of 
this work, it is important to remember that Terlecky 
and colleagues in 2006 postulated the existence of 
a self-sustaining peroxisome deterioration spiral 
(35). According to this model, peroxisomes are 
predisposed to oxidative stress due to a 
dysregulated import of peroxisomal H2O2-producing 
oxidases, which in general bear a strong PTS1 (36), 
and catalase, which contains a weak PTS1 (37). 
This causes the organelle to slowly lose its ability to 
clear generated ROS, and – as such – its import 
machinery may become gradually compromised. 
This, in turn, will initially mainly affect the import of 
weak substrates, such as catalase, but later on 
result in a self-perpetuating negative protein import 
spiral causing oxidative stress and peroxisome 
dysfunction (6,35). The data presented in this 
manuscript extend this theory by providing specific 
details regarding the potential mechanisms by which 
cellular oxidative stress causes peroxisomal protein 
import defects. Note that, as the monoubiquitinable 
cysteine residue in the N-terminus of PEX5 and the 
weak PTS1 of catalase are highly conserved in 
virtually all mammalian species (data not shown), it 
is tempting to speculate that these features have 
evolved because of a possible advantage. For 
example, a decrease in the peroxisomal import 
efficiency of (newly-synthesized) catalase may allow 
cells to rapidly respond to oxidative stress in the 
cytosol. This postulate is in line with a recent study 
showing that p97, an ATPase of the AAA family 
(ATPases with diverse cellular activities), can 
regulate H2O2 levels in the cytosol by affecting the 
 4
retention time of (newly-synthesized) catalase within 
this subcellular compartment (38). 
Importantly, when the work presented in this 
manuscript was in a final stage, Subramani and 
coworkers reported that also Pichia pastoris Pex5 
(PpPex5) functions as a redox-regulated PTS1 
protein import receptor (39). Specifically, these 
authors reported that Cys10, the evolutionarily 
conserved redox-sensitive cysteine in PpPex5, acts 
as a redox switch to control the binding and release 
of PTS1 proteins to and from PpPex5 by modulating 
its oligomeric state. Based on these observations 
and a report stating that the intraperoxisomal redox 
state is more reductive than that of the cytosol (40), 
the authors postulated a working model in which 
(oxidized) disulfide bond-linked PpPex5 binds 
newly-synthesized PTS1 proteins in the cytosol and 
releases these proteins upon reduction in the 
peroxisomal matrix. However, here it is important to 
note that this model is not compatible with our data. 
Indeed, we clearly show that the reduced 
functionality of PEX5 in an oxidizing environment 
can be counteracted by substituting Cys11 with 
lysine, and this finding in turn strongly indicates that 
– at least for human PEX5 – oxidation-mediated 
disulfide bond formation through this conserved 
cysteine can be functionally uncoupled from PTS1 
cargo binding and release. In this context, it is also 
important to point out that some of us have 
previously shown that, in a mammalian system, (i) 
PTS1 proteins can be efficiently imported into 
peroxisomes under conditions in which the redox 
state of peroxisomes is more oxidizing than that of 
the cytosol (23), (ii) the release of PTS1 cargo 
proteins into the peroxisomal matrix is most likely 
triggered by binding of PEX14 to the 6th (and 
probably 7th) diaromatic motif(s) of PEX5 (41), and 
(iii) PEX5C11A, a mutant of PEX5 that is not capable 
of forming a disulfide bond through the conserved 
cysteine, can translocate PTS1 proteins across the 
peroxisomal membrane and release these proteins 
into the organellar matrix as efficient as PEX5WT, at 
least in a cell-free in vitro import system (as 
PEX5C11A cannot be monoubiquitinated at the 
peroxisomal membrane and hence not be exported 
back to the cytosol, this protein abrogates PTS1 
protein import upon expression in wild-type cells) 
(21,42). Nevertheless, as yeast and mammalian 
systems are not always directly comparable 
because of differences in PEX proteins and enzyme 
content (9), it remains to be established whether or 
not the apparently conflicting data obtained for 
PpPex5p and human PEX5 represent species- or 
condition-specific characteristics. 
In conclusion, our data provide clear evidence that 
(i) the activity of PEX5 depends on the redox state 
of the cytosol, and (ii) this redox sensitivity is 
mediated by Cys11, an evolutionarily conserved 
amino acid involved in receptor monoubiquitination 
and recycling. These findings are relevant for a 
better understanding of how cellular oxidative stress 
may contribute to a demise of peroxisome function, 
a condition associated with cellular senescence, 
organismal aging, and age-related diseases (4). 
Materials and Methods 
DNA manipulations and plasmids – The 
mammalian expression vector pIRES2-EGFP and 
the restriction enzymes were commercially obtained 
from Westburg (Leusden, The Netherlands). 
Oligonucleotides (Supplementary Table 1) were 
synthesized by Integrated DNA Technologies (IDT, 
Leuven, Belgium). Polymerase chain reactions were 
routinely carried out by using Pfx DNA Polymerase 
(Invitrogen, Merelbeke, Belgium). The E. coli strain 
Top10F’ (Invitrogen) was used for all DNA 
manipulations. The plasmids encoding a cytosolic 
roGFP2 (roGFP2; pMF1707), peroxisomal roGFP2 
(roGFP2-PTS1; pMF1706), or human catalase 
(pMF1525) have been described elsewhere (23). 
The pIRES2-roGFP2-PTS1 (pMN8) plasmid was 
constructed via a three-point ligation of the following 
fragments: (i) the XmaI/NotI-restricted backbone 
fragment of pIRES2-GFP, (ii) a XmaI/BamHI-
restricted PCR fragment comprising the IRES2 
sequence (template: pIRES2-EGFP2; primers: 
pIRES2fwXmaI and pIRES2rvBamHI), and (iii) the 
BamHI/NotI restricted fragment of pMF1706, which 
encodes roGFP2-PTS1. The bicistronic constructs 
encoding roGFP2-PTS1 in combination with the 
large isoform of HsPEX5WT (pDC2) or HsPEX5C11K 
(pDC1) were generated by amplifying the 
corresponding HsPEX5-encoding cDNA fragments 
by PCR (templates: pMF1678 and pMF1578, 
respectively (13); primers: HsPex5.1fw and 
HsPex5.2rv) and cloning the BglII/SalI-digested 
PCR products into the BglII/SalI-restricted pIRES2-
roGFP2-PTS1 vector. All plasmids were verified by 
DNA sequencing (LGC Genomics, Berlin, 
Germany). The pGEM4 (Promega)-based 
plasmids encoding the large isoform of human 
PEX5 and the mutated version of it possessing a 
lysine at position 11 (PEX5C11K) have been 
previously described (13,43). 
Cell culture, transfections and fluorescence 
microscopy – The primary PEX5 null human 
fibroblasts (HuFs; cell line PBD005) have been 
described elsewhere (44,45). Briefly, these cells are 
homozygous for a mutation (Arg390Ter) in the 
PEX5 gene that results in a complete inactivation of 
PEX5’s normal function (44,45). Control HuFs were 
kindly provided by Dr. D. Cassiman (KU Leuven, 
Belgium). Where indicated, the cell lines were 
transformed by introduction of SV40 large T-
antigen. Unless specified otherwise, all cell lines 
were cultivated at 37°C in a humidified 5% CO2 
incubator in minimum essential medium Eagle alpha 
(MEMα; Lonza, Verviers, Belgium) supplemented 
with 10% (v/v) heat-inactivated fetal bovine serum 
(Invitrogen), 2 mM Glutamax (Invitrogen), and 
MycoZap (Lonza). The cells were transfected by 
using the Neon Transfection System (Invitrogen; 
primary HuFs: 1200 V, 20-ms pulse width, 1 pulse; 
transformed HuFs: 1300 V, 30-ms pulse width, 1 
pulse). Cells for live-cell imaging were seeded and 
imaged in FD-35 Fluorodish cell culture dishes 
(World Precision Instruments, Hertfordshire, 
England). The technical specifications of the 
objectives, excitation and emission filters, and digital 
camera have been described elsewhere (46). 
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Ratiometric redox measurements were performed 
as described (23). Note that, as the spectral output 
of the replacement lamps was not always identical, 
the emission ratios of roGFP2 at the 400- and 480-
nm excitation wavelengths were expressed in 
arbitrary units (a.u.). The Olympus image analysis 
and particle detection software were used for 
quantitative image analysis. 
Peroxisome-dependent PEX5-ubiquitination 
assay – 35S-labeled PEX5 and PEX5C11K were 
synthesized in rabbit reticulocyte lysates using the 
TNT® quick coupled transcription/translation system 
(Promega) in the presence of EasyTag™ L-
(35S)methionine (specific activity, >1000 Ci/mmol; 
PerkinElmer Life Sciences) and the pGEM4®-based 
plasmids referred to above. Rat liver postnuclear 
supernatant (PNS; 600 µg of protein) was diluted in 
import buffer (0.25 M sucrose, 50 mM KCl, 20 mM 
MOPS-KOH pH 7.2, 3 mM MgCl2, 20 µM 
methionine, and 2 µg/ml N-(trans-epoxysuccinyl)-L-
leucine 4-guanidinobutylamide) containing 0.3 mM 
ATP (final volume 80 µl), and primed for import by 
incubating the samples for 5 min at 37 °C (47). The 
samples were placed on ice, and incubated for 10 
min in the absence or presence of increasing 
concentrations oxidized glutathione (GSSG; added 
from a 0.1 M stock solution in 20 mM MOPS-KOH, 
pH 7.4). In parallel, 1 µl of 35S-labeled PEX5WT or 
PEX5C11K (diluted 1:20 (v/v) in import buffer) were 
also treated with the matching GSSG concentration. 
Next, the diluted lysates were added to the 
corresponding PNS mixtures, and the samples were 
incubated for 20 min at 37 °C in the presence of 5 
mM ATP and 7 µM glutathione S-transferase (GST)-
ubiquitin (20). The reactions were stopped with 20 
mM N-ethylmaleimide (NEM; 5 min on ice), diluted 
with 900 µl of ice-cold SEMK buffer (0.25 M 
sucrose, 80 mM KCl, 20 mM MOPS-KOH, pH 7.2, 1 
mM EDTA-NaOH, pH 8.0), and centrifuged at 
16,000 x g for 20 min at 4°C to separate the 
organelles from soluble proteins. The organelle 
pellets were then subjected to SDS-PAGE under 
non-reducing (no DTT) and reducing (0.1 M DTT) 
conditions, and analyzed by Western blot and 
autoradiography, as described before (13,20). 
Statistical analysis – Statistics were performed on 
the VassarStats statistical computation website 
(http://vassarStats.net/). One-way analysis of 
variance was used to determine the differences 
among independent groups of numerical values, 
and individual differences were further explored with 
a Student’s t-test. The significance level was chosen 
to be p<0.01. 
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Figure legends 
Figure 1. The efficiency of PTS1 protein import into 
peroxisomes is influenced by the cytosolic redox 
state. Primary human fibroblasts (HuFs) (passages 
15 or 35) were transiently transfected with a plasmid 
encoding peroxisomal (roGFP2-PTS1) or cytosolic 
(roGFP2) roGFP2, in combination or not with a 
plasmid encoding wild-type catalase (cat). The cells 
were cultivated in standard growth medium and, 
where indicated, supplemented with 0.5 mM DTT 
(overnight before analysis). (A) Subcellular 
localizations of roGFP2-PTS1 in late passage cells. 
Note that, as (i) the cytosolic redox state of these 
cells displays a considerable intercellular variability 
(23), and (ii) this variability substantially influences 
the import efficiency of PTS1 proteins (this study), 
different cells can display a different distribution 
pattern for roGFP2-PTS1. PO, peroxisomes; C, 
cytosol; PO/C, peroxisomes and cytosol. Scale bar: 
10 µm. (B) Box plot representations of the 400/480 
nm fluorescence response ratios of roGFP2 at 6 
days post-transfection. The results are normalized 
to the average value of the ‘p15’ condition, which is 
set to one arbitrary unit (a.u.). The bottom and top of 
each box represent the 25th and 75th percentile 
values, respectively; the horizontal line inside each 
box represents the median; and the horizontal lines 
below and above each box denote the mean minus 
and plus one standard deviation, respectively. The 
number of randomly chosen measurements (from at 
least 6 different cells) is indicated below each box 
plot. The data were statistically compared. (C) 
Distribution pattern of roGFP2-PTS1 at 3 days post-
transfection: PO (black boxes), C (white boxes), or 
PO/C (grey boxes). The number of cells analyzed is 
indicated above each condition. 
Figure 2. The cysteine at position 11 of human 
PEX5 mediates the oxidative stress-related decline 
in PTS1 import efficiency. Primary (P; passage 
number: 24) and SV40 T-antigen-transformed (T) 
PEX5 null human fibroblasts (HuFs) were transiently 
transfected with a plasmid encoding peroxisomal 
(roGFP2-PTS1) or cytosolic (roGFP2) roGFP2, in 
combination or not with a plasmid encoding 
HsPEX5WT (5WT) or HsPEX5C11K (5C11K). The cells 
were cultivated in the standard growth medium and 
analyzed 3 days post-transfection. (A) Subcellular 
localizations of roGFP2-PTS1: peroxisomes (PO, 
black boxes), cytosol (C, white boxes), or 
peroxisomes/cytosol (PO/C, grey boxes); 100 
randomly selected cells were analyzed per 
condition. (B) Box plot representations of the 
400/480 nm fluorescence response ratios of 
roGFP2. The results are normalized to the average 
value of the corresponding late-passage primary 
cells, which is set to one arbitrary unit (a.u.). The 
number of randomly chosen measurements (from at 
least 10 different cells) is indicated below each box 
plot. For a description of these plots, see legend of 
Figure 1. The data were statistically compared. 
Figure 3. The efficiency of PTS1 protein import 
complementation in aged primary PEX5 null human 
fibroblasts is affected by the redox state of the 
cytosol and the identity of the ubiquitinatable 
residue near the N-terminus of human PEX5. 
Primary PEX5 null human fibroblasts (HuFs; 
passage number: 25) were transiently transfected 
with a monocistronic plasmid encoding cytosolic 
roGFP2 (roGFP2) or a bicistronic plasmid encoding 
peroxisomal roGFP2 (roGFP2-PTS1) and wild-type 
HsPEX5 (5wt) or HsPEX5C11K (5C11K). After three 
days, the standard growth medium was replaced by 
fresh medium supplemented (+NAC) or not (-NAC) 
with 1 mM N-acetyl-cysteine. The cells were 
analyzed at the indicated time points. (A) Box plot 
representations of the 400/480 nm fluorescence 
response ratios of roGFP2. The results are 
normalized to the average value of the ‘0 h’ 
condition, which is set to one arbitrary unit (a.u.). 
The number of randomly chosen measurements 
(from at least 15 individual cells) is indicated below 
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each box plot. For a description of these plots, see 
legend of Figure 1B. (B, C) Subcellular localization 
of roGFP2-PTS1 under different treatment 
conditions (plotted as a function of time). PO, 
peroxisomal localization; PO/C, mixed peroxisomal 
and cytosolic localization. 
Figure 4. Oxidized glutathione interferes with 
monoubiquitination of human PEX5 at Cys11. 35S-
labeled PEX5WT and PEX5C11K were subjected to in 
vitro import reactions (supplemented with GST-Ub) 
in the absence or presence of increasing 
concentrations of oxidized glutathione (GSSG) (for 
more details, see “Materials and Methods”). After 20 
minutes, the samples were treated with NEM, and 
the organelles were isolated by centrifugation. The 
organelle fractions were subjected to SDS-PAGE 
under non-reducing (-DTT) and reducing (+DTT) 
conditions, and blotted onto a nitrocellulose 
membrane. The membrane was exposed to an X-
ray film. Lane I, 10% of the 35S-labeled PEX5 
reticulocyte lysate used in each lane. The numbers 
to the left indicate the migration of the molecular 
mass markers (in kDa). 
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Supplementary Table 1. List of oligonucleotides used in this study* 
Name Nucleotide sequence 
HsPex5.1fw 5’- cgagatctgtatggcaatgcgggagctgg -3' 
HsPex5.2rv 5’- gcccgtcgacctgtcactggggcaggccaaac -3’ 
pIRES2fwXmaI 5’- tgaacccgggttccgcccctctccctc -3’ 
pIRES2rvBamHI 5’- gggggatccttgtggccatattatcatcg -3’ 
* Restriction sites are underlined 
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